First-Line Treatment for GERD: PPIs Over H2 Blockers
Proton pump inhibitors (PPIs) are the first-line treatment for GERD, not H2 blockers. PPIs should be prescribed as a single daily dose taken 30-60 minutes before a meal for an initial 4-8 week trial 1.
Why PPIs Are Superior
The evidence strongly favors PPIs over H2 receptor antagonists:
- PPIs provide superior acid suppression, maintaining intragastric pH above 4.0 for longer periods, which directly correlates with symptom relief and mucosal healing 2
- Faster symptom relief: PPIs relieve heartburn more rapidly than H2RAs 3, 2
- Better healing rates: PPIs are significantly more effective at healing erosive esophagitis and esophageal ulcers 2
- Cost-effectiveness: The "PPI-first" strategy is superior to the "step-up" approach (starting with H2RAs) in both clinical outcomes and cost-effectiveness 4
Practical Implementation
Initial therapy approach 1:
- Start any commercially available PPI (choice guided by insurance coverage and cost)
- Dose: Single daily dose, 30-60 minutes before a meal
- Duration: 4-8 week trial
- Reassess symptoms after the trial period
If inadequate response 1:
- Increase to twice-daily dosing, OR
- Switch to a more potent PPI (rabeprazole, esomeprazole) or extended-release formulation (dexlansoprazole)
After symptom control 1:
- Taper to the lowest effective dose
- Perform routine re-evaluation of treatment necessity
Role of H2 Blockers
H2RAs have limited utility as primary treatment and are now considered inferior to PPIs 5. Their current role is primarily as adjunctive therapy in PPI-refractory cases, particularly for nocturnal acid breakthrough when added to twice-daily PPI therapy 6, 5.
Common Pitfall to Avoid
Timing matters: Patients must take PPIs 30-60 minutes before meals for optimal efficacy 1. Improper timing is a common cause of treatment failure. Provide patient education emphasizing this critical detail and reassure patients about PPI safety for GERD treatment 1.
When to Pursue Further Evaluation
If symptoms persist after 4-8 weeks of PPI therapy, or if alarm symptoms are present, proceed to endoscopy and objective reflux testing rather than continuing empiric dose escalation 1.